Next week, from 14 to 17 November, the team from Atomo Diagnostics will be at the world’s largest annual medical trade fair – Medica.  The 4-day event, held in Dusseldorf, Germany, is expected to attract over 130,000 healthcare industry professionals from more than 120 countries.  We will be showcasing our award-winning AtomoRapid™ diagnostic platforms at our booth, F19 in Hall 1.

One of Atomo’s valued OEM partners, NG Biotech, is also using Medica to unveil its new lateral flow test, NG-Test® Blood Precision hCG, the first fully-integrated blood-based rapid test for detection of hCG levels in pregnancy.  The product has been developed in conjunction with Atomo and is designed to overcome the issues inherent with laboratory-based blood analysis and urine rapid testing.

From 2017, NG-Test® Blood Precision hCG will be available for use throughout Europe and, thereafter, regulatory approval will be sought for commercialization in the US.  Additionally, because of the product’s unmatched usability, NG Biotech intends to seek regulatory approval for an OTC version for lay users.  This will give women the ability to test for pregnancy at an early stage with the greater convenience and precision offered by painless blood-based testing.

Requiring only a small blood sample of 10uL, collected easily and comfortably from the fingertip, the test delivers a highly accurate result at any time of day, in contrast to urine tests that have to be used with the first morning urine for utmost accuracy in early stage pregnancy.  NG Biotech will be presenting the product at its booth, H74 in Hall 3.

If you’re going to Medica, be sure to stop by to see Atomo’s design and development capabilities close up.  Or contact us today to discuss how our next generation, all-in-one lateral-flow test platforms can be used to enhance rapid diagnostic testing – info@atomodiagnostics.com.